- Exchanges
- BSE, NSE
- Issue
- Book building
Anthem Biosciences IPO
₹730.35
+28.13% on listing
Listing-day close · NSE · 21 Jul 2025 · issue price ₹570
Anthem Biosciences’ ₹3,395 crore IPO was priced at ₹570 a share. It listed on the NSE on 21 Jul 2025 and closed its first day at ₹730.35, up 28.13% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹3,395 Cr
- Fresh issue
- —
- Offer for sale
- ₹3,395 Cr
- Lot size
- 26 shares
- Minimum investment
- ₹14,820
- Face value
- ₹2
- Registrar
- Kfin Technologies
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 47.37× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹31,867 Cr
- P/E (post-issue)
- 70.6
- EPS (post-issue)
- ₹8.07
- Price to book
- 13.2
- ROE
- 20.82%
- ROCE
- 26.88%
- Debt to equity
- 0.05
- EBITDA margin
- 36.81%
- PAT margin
- 23.38%
- Promoter holding
- 76.87% → 74.68%
Financials as of 31 Mar 2025, from the offer documents.
Listing
- Listing date
- 21 Jul 2025
- Issue price
- ₹570
- Open
- ₹723.05
- High
- ₹747.00
- Low
- ₹723.05
- Close
- ₹730.35
Listing day on the NSE. The close was +28.13% on the issue price.
ANTHEM BIOSCIENCES share price todayFAQs
When did the Anthem Biosciences IPO open and close?
It opened on 14 Jul 2025 and closed on 16 Jul 2025.
What was the Anthem Biosciences IPO price?
The price band was ₹540–570 a share. The final issue price was ₹570.
What is the lot size and minimum investment?
One lot is 26 shares, ₹14,820 at ₹570 a share. Retail investors apply in whole lots.
How much did Anthem Biosciences raise?
₹3,395 crore: ₹3,395 crore offered by existing shareholders.
How many times was the Anthem Biosciences IPO subscribed?
47.37 times overall.
How did Anthem Biosciences list?
It listed on the NSE on 21 Jul 2025 at ₹723.05 and closed the day at ₹730.35, up 28.13% on the ₹570 issue price.
Who is the registrar of the Anthem Biosciences IPO?
Kfin Technologies handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app